PVLA · Palvella Therapeutics, Inc. · Debt
$125.10
-1.29 (-1.02%)
At close · Oct 23
Return incl. dividend (before tax)
Market Cap
$1.80B
Shares
14.41M
Volume · Oct 23
164.22K
Avg daily vol (3M)
206.62K
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Current operating lease liabilities | 2026-06-30 | USD 217,000 | 10-Q filed 2026-08-04 |
| Noncurrent operating lease liabilities | 2026-06-30 | USD 318,000 | 10-Q filed 2026-08-04 |
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.
Key facts
CIK
1583648
CUSIP
697947109
13F (30d)
22 filings
22 filers
Visit website
Investor relations